Kyoto Bio Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Kyoto Bio Pharma Llp

Kyoto Bio Pharma Llp, a active limited liability partnership, was established on 04 October 2016 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAH-5346. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Yugandhara Rajesh Katkar (Designated Partner), Rajnikant Nalawade Annasaheb (Designated Partner), Sunita Rajesh Katkar (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at B-25, Gr Flr, Station Plaza Commercial Premises Station Road, Bhandup (West, Mumbai, Maharashtra, 400078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAH-5346

  • Incorporation Date

    04 October 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Kyoto Bio Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kyoto Bio Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kyoto Bio Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Yugandhara Rajesh Katkar Designated Partner 04 Oct 2016 Current
Rajnikant Nalawade Annasaheb Designated Partner 04 Oct 2016 Current
Sunita Rajesh Katkar Designated Partner 04 Oct 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kyoto Bio Pharma Llp.

Enhance accessibility to Kyoto Bio Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kyoto Bio Pharma Llp revenue growth over time
Kyoto Bio Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kyoto Bio Pharma Llp?

Unlock access to Kyoto Bio Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kyoto Bio Pharma Llp?

Unlock and access historical data on people associated with Kyoto Bio Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kyoto Bio Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyoto Bio Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kyoto Bio Pharma Llp
Recent Activity within the Organization
  • Statement of Assets & Liabilities

    Kyoto Bio Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Annual General Meeting

    Progress on Kyoto Bio Pharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was documented.

  • Director Appointment

    Yugandhara Rajesh Katkar was appointed as a Designated Partner was appointed as a Designated Partner on 04 Oct 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Rajnikant Nalawade Annasaheb was appointed as a Designated Partner was appointed as a Designated Partner on 04 Oct 2016 & has been associated with this company since 9 years 4 months . was completed.

  • Director Appointment

    The activity Sunita Rajesh Katkar was appointed as a Designated Partner was appointed as a Designated Partner on 04 Oct 2016 & has been associated with this company since 9 years 4 months . was completed.

  • LLP Incorporation

    Kyoto Bio Pharma Llp was registered on 04 Oct 2016 with Roc Mumbai & aged 9 years 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Kyoto Bio Pharma Llp?

The LLPIN of Kyoto Bio Pharma Llp is AAH-5346.

Where is Kyoto Bio Pharma Llp headquartered?

Kyoto Bio Pharma Llp is headquartered at B-25, Gr Flr, Station Plaza Commercial Premises Station Road, Bhandup (West, Mumbai, Maharashtra, 400078.

When was Kyoto Bio Pharma Llp incorporated?

Kyoto Bio Pharma Llp was incorporated on 04 October 2016.

Who are the current directors of Kyoto Bio Pharma Llp?

The current directors of Kyoto Bio Pharma Llp are

What is the primary industry of Kyoto Bio Pharma Llp?

The primary industry of Kyoto Bio Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available